Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 92

1.

The Shigella dysenteriae serotype 1 proteome, profiled in the host intestinal environment, reveals major metabolic modifications and increased expression of invasive proteins.

Pieper R, Zhang Q, Parmar PP, Huang ST, Clark DJ, Alami H, Donohue-Rolfe A, Fleischmann RD, Peterson SN, Tzipori S.

Proteomics. 2009 Nov;9(22):5029-45. doi: 10.1002/pmic.200900196.

2.

In vivo versus in vitro protein abundance analysis of Shigella dysenteriae type 1 reveals changes in the expression of proteins involved in virulence, stress and energy metabolism.

Kuntumalla S, Zhang Q, Braisted JC, Fleischmann RD, Peterson SN, Donohue-Rolfe A, Tzipori S, Pieper R.

BMC Microbiol. 2011 Jun 24;11:147. doi: 10.1186/1471-2180-11-147.

3.

Proteomes of pathogenic Escherichia coli/Shigella group surveyed in their host environments.

Suh MJ, Kuntumalla S, Yu Y, Pieper R.

Expert Rev Proteomics. 2014 Oct;11(5):593-609. doi: 10.1586/14789450.2014.935342. Epub 2014 Aug 28. Review.

PMID:
25163594
4.

IpaD of Shigella flexneri is independently required for regulation of Ipa protein secretion and efficient insertion of IpaB and IpaC into host membranes.

Picking WL, Nishioka H, Hearn PD, Baxter MA, Harrington AT, Blocker A, Picking WD.

Infect Immun. 2005 Mar;73(3):1432-40.

5.

Isolation of Shigella dysenteriae type 1 and S. flexneri strains from surface waters in Bangladesh: comparative molecular analysis of environmental Shigella isolates versus clinical strains.

Faruque SM, Khan R, Kamruzzaman M, Yamasaki S, Ahmad QS, Azim T, Nair GB, Takeda Y, Sack DA.

Appl Environ Microbiol. 2002 Aug;68(8):3908-13.

6.

OspF and OspC1 are Shigella flexneri type III secretion system effectors that are required for postinvasion aspects of virulence.

Zurawski DV, Mitsuhata C, Mumy KL, McCormick BA, Maurelli AT.

Infect Immun. 2006 Oct;74(10):5964-76.

7.

RyhB, an iron-responsive small RNA molecule, regulates Shigella dysenteriae virulence.

Murphy ER, Payne SM.

Infect Immun. 2007 Jul;75(7):3470-7. Epub 2007 Apr 16.

8.

The Many Faces of IpaB.

Picking WL, Picking WD.

Front Cell Infect Microbiol. 2016 Feb 9;6:12. doi: 10.3389/fcimb.2016.00012. eCollection 2016. Review.

9.

Differential host immune responses to epidemic and endemic strains of Shigella dysenteriae type I.

Sayem MA, Ahmad SM, Rekha RS, Sarker P, Agerberth B, Talukder KA, Raqib R.

J Health Popul Nutr. 2011 Oct;29(5):429-37.

10.

Analysis of the proteome of intracellular Shigella flexneri reveals pathways important for intracellular growth.

Pieper R, Fisher CR, Suh MJ, Huang ST, Parmar P, Payne SM.

Infect Immun. 2013 Dec;81(12):4635-48. doi: 10.1128/IAI.00975-13. Epub 2013 Oct 7.

11.

How Do the Virulence Factors of Shigella Work Together to Cause Disease?

Mattock E, Blocker AJ.

Front Cell Infect Microbiol. 2017 Mar 24;7:64. doi: 10.3389/fcimb.2017.00064. eCollection 2017. Review.

12.

Domains of the Shigella flexneri type III secretion system IpaB protein involved in secretion regulation.

Shen DK, Saurya S, Wagner C, Nishioka H, Blocker AJ.

Infect Immun. 2010 Dec;78(12):4999-5010. doi: 10.1128/IAI.00470-10. Epub 2010 Oct 11.

13.

A novel serovar of Shigella dysenteriae from patients with diarrhoea in Bangladesh.

Talukder KA, Mondol AS, Islam MA, Islam Z, Dutta DK, Khajanchi BK, Azmi IJ, Hossain MA, Rahman M, Cheasty T, Cravioto A, Nair GB, Sack DA.

J Med Microbiol. 2007 May;56(Pt 5):654-8.

PMID:
17446289
14.

A novel Shigella dysenteriae serovar isolated in Canada.

Melito PL, Woodward DL, Munro J, Walsh J, Foster R, Tilley P, Paccagnella A, Isaac-Renton J, Ismail J, Ng LK.

J Clin Microbiol. 2005 Feb;43(2):740-4.

15.

IpaD localizes to the tip of the type III secretion system needle of Shigella flexneri.

Espina M, Olive AJ, Kenjale R, Moore DS, Ausar SF, Kaminski RW, Oaks EV, Middaugh CR, Picking WD, Picking WL.

Infect Immun. 2006 Aug;74(8):4391-400.

16.

Preparation and characterization of translocator/chaperone complexes and their component proteins from Shigella flexneri.

Birket SE, Harrington AT, Espina M, Smith ND, Terry CM, Darboe N, Markham AP, Middaugh CR, Picking WL, Picking WD.

Biochemistry. 2007 Jul 10;46(27):8128-37. Epub 2007 Jun 16.

PMID:
17571858
17.

Characterization of a novel fusion protein from IpaB and IpaD of Shigella spp. and its potential as a pan-Shigella vaccine.

Martinez-Becerra FJ, Chen X, Dickenson NE, Choudhari SP, Harrison K, Clements JD, Picking WD, Van De Verg LL, Walker RI, Picking WL.

Infect Immun. 2013 Dec;81(12):4470-7. doi: 10.1128/IAI.00859-13. Epub 2013 Sep 23.

18.

Cloning, expression, and affinity purification of recombinant Shigella flexneri invasion plasmid antigens IpaB and IpaC.

Picking WL, Mertz JA, Marquart ME, Picking WD.

Protein Expr Purif. 1996 Dec;8(4):401-8.

PMID:
8954886
19.

The extreme C terminus of Shigella flexneri IpaB is required for regulation of type III secretion, needle tip composition, and binding.

Roehrich AD, Martinez-Argudo I, Johnson S, Blocker AJ, Veenendaal AK.

Infect Immun. 2010 Apr;78(4):1682-91. doi: 10.1128/IAI.00645-09. Epub 2010 Jan 19.

20.

Molecular mechanisms of host cytoskeletal rearrangements by Shigella invasins.

Lee JH, Park H, Park YH.

Int J Mol Sci. 2014 Oct 10;15(10):18253-66. doi: 10.3390/ijms151018253. Review.

Supplemental Content

Support Center